David Goodman

David Goodman's lobbying: the registrations they file and every meeting they've reported since November 2021.

Registrant (responsible officer)

Chief Executive Officer

For companies and organizations, the most senior paid officer files the registration and the monthly reports, whoever attended the meeting.

Meetings this Parliament: 175
Since Nov 2021: 205
Active registrations: 1

Reported meetings

Apr 29, 2026 Pharmascience Inc.
- Cyril Nawar · Conseiller regional pour le Quebec de Carlos Leitao, House of Commons
Policies aimed at reinforcing pharmaceutical supply chain.

Official report
Apr 28, 2026 Pharmascience Inc.
- Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
- Loris Mirella · Directeur, Global Affairs Canada (GAC)
- Daniel MacDonald · Director General, Office of Pharmaceutical Management Strategies, Health Canada (HC)
Policies aimed at reinforcing pharmaceutical supply chain.

Official report
Apr 28, 2026 Pharmascience Inc.
- Ritu Banerjee · Sous-ministre adjoint(e), Innovation, Science and Economic Development Canada (ISED)
- Caroline Menard · Gestionnaire, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain. Read more

Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.

Official report
Apr 27, 2026 Pharmascience Inc.
- Joël Raby Fernandes · Adjoint parlementaire, House of Commons
Policies aimed at reinforcing pharmaceutical supply chain.

Official report
Apr 27, 2026 Pharmascience Inc.
- Brandan Rowe · Chef de cabinet, Privy Council Office (PCO)
- Miro Froehlich · Directeur des politiques, Privy Council Office (PCO)
- Galen Richardson · Conseiller(e) principale Rélations avec les parties prenantes, Privy Council Office (PCO)
Policies aimed at reinforcing pharmaceutical supply chain.

Official report
Apr 27, 2026 Pharmascience Inc.
- Mélanie Joly · Ministre de l'Industrie et ministre responsable pour le développement économique Canada pour les régions du Québec, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.

Official report
Apr 27, 2026 Pharmascience Inc.
- Cyril Nawar · Conseiller regional pour le Quebec de Carlos Leitao, House of Commons
Policies aimed at reinforcing pharmaceutical supply chain.

Official report
Apr 26, 2026 Pharmascience Inc.
- Joël Raby Fernandes · Adjoint parlementaire, House of Commons
Policies aimed at reinforcing pharmaceutical supply chain.

Official report
Apr 26, 2026 Pharmascience Inc.
- Cyril Nawar · Conseiller regional pour le Quebec de Carlos Leitao, House of Commons
Policies aimed at reinforcing pharmaceutical supply chain.

Official report
Apr 24, 2026 Pharmascience Inc.
- Shalene Curtis-Micallef · Sous-ministre, Health Canada (HC)
- Pamela Aung-Thin · Assistant Deputy Minister, Health Canada (HC)
Policies aimed at reinforcing pharmaceutical supply chain.

Official report
Apr 24, 2026 Pharmascience Inc.
- Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.

Official report
Apr 23, 2026 Pharmascience Inc.
- Joël Raby Fernandes · Adjoint parlementaire, House of Commons
Policies aimed at reinforcing pharmaceutical supply chain.

Official report
Apr 23, 2026 Pharmascience Inc.
- Cyril Nawar · Conseiller regional pour le Quebec de Carlos Leitao, House of Commons
Policies aimed at reinforcing pharmaceutical supply chain.

Official report
Apr 23, 2026 Pharmascience Inc.
- Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.

Official report
Apr 17, 2026 Pharmascience Inc.
- Maxime Blanchette-Joncas · Député
Policies aimed at reinforcing pharmaceutical supply chain.

Official report
Apr 17, 2026 Pharmascience Inc.
- Shalene Curtis-Micallef · Sous-ministre, Health Canada (HC)
Policies aimed at reinforcing pharmaceutical supply chain.

Official report
Apr 16, 2026 Pharmascience Inc.
- Dominic LeBlanc · Président du Conseil privé du Roi pour le Canada et Ministre du Commerce international et des Affaires intergouvernementales
Policies aimed at reinforcing pharmaceutical supply chain.

Official report
Apr 16, 2026 Pharmascience Inc.
- Mélanie Joly · Ministre de l'Industrie et ministre responsable pour le développement économique Canada pour les régions du Québec, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.

Official report
Apr 16, 2026 Pharmascience Inc.
- Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Policies aimed at reinforcing pharmaceutical supply chain.

Official report
Apr 16, 2026 Pharmascience Inc.
- Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.

Official report
Apr 15, 2026 Pharmascience Inc.
- Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Seeking support from the Strategic Innovation Fund Program for support of biomanufacturing expansion project.

Official report
Apr 15, 2026 Pharmascience Inc.
- Cyril Nawar · Conseiller regional pour le Quebec de Carlos Leitao, House of Commons
Policies aimed at reinforcing pharmaceutical supply chain.

Official report
Apr 15, 2026 Pharmascience Inc.
- Chanel Sterie · Conseillère principale, Public Services and Procurement Canada (PSPC)
- Loic Senechal · Conseiller regional pour le Quebec et adjoint communications, Public Services and Procurement Canada (PSPC)
Policies aimed at reinforcing pharmaceutical supply chain.

Official report
Apr 10, 2026 Pharmascience Inc.
- Loic Sénéchal · Conseiller regional pour le Quebec, Public Services and Procurement Canada (PSPC)
Policies aimed at reinforcing pharmaceutical supply chain.

Official report
Apr 9, 2026 Pharmascience Inc.
- Loic Sénéchal · Conseiller regional pour le Quebec, Public Services and Procurement Canada (PSPC)
Policies aimed at reinforcing pharmaceutical supply chain.

Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.